Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseLuke Jostins, Ailsa Hart, Ken Hui et al.|Nature|2012Cited by 4.8k
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort StudyVince Biemans, Frank Hoentjen, Andrea E. van der Meulen‐de Jong et al.|Journal of Crohn s and Colitis|2019Cited by 183
Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatmentVince Biemans, C. Janneke van der Woude, Gerard Dijkstra et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 129